Can ParC Ser83Ile status predict fluoroquinolone efficacy in Mycoplasma genitalium infection? - Authors' reply.

Saved in:
Bibliographic Details
Title: Can ParC Ser83Ile status predict fluoroquinolone efficacy in Mycoplasma genitalium infection? - Authors' reply.
Authors: Sweeney EL; The University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia. Electronic address: e.l.sweeney@uq.edu.au., Bradshaw CS; Melbourne Sexual Health Centre, Alfred Hospital and Central Clinical School, Carlton, VIC, Australia., Murray GL; The Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, VIC, Australia; Centre for Women's Infectious Diseases, The Royal Women's Hospital, Parkville, VIC, Australia; Molecular Microbiology Research Group, Murdoch Children's Research Institute, Parkville, VIC, Australia., Whiley DM; The University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia; Pathology Queensland Central Laboratory, Brisbane, QLD, Australia.
Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Sep; Vol. 22 (9), pp. 1274-1275.
Publication Type: Letter; Comment
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-4457
DOI:10.1016/S1473-3099(22)00446-7